| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.29 | 0.07 |